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Abstract  
Background: The objective of the study was to assess the implementation and the performance of recommended collaborative TB/HIV activities 
in Batibo District Hospital (BDH) and to determine the prevalence of HIV in TB patients in this rural locality. Methods: The implementation of 
collaborative TB/HIV activities was assessed through interviews with health workers in the hospital. The implementation score was calculated as 
the proportion of recommended activities effectively implemented in the hospital. The performance of implemented activities and the prevalence of 
HIV  were  determined  through  review  in  HIV  and  TB  registers  of  routine  data  for  the  period  2003-2008.  Results:  The  implementation  of 
collaborative  TB/HIV  activities  though  triggered  by  the  existence  of  both  TB  and  HIV  units  in  the  hospital  was  only  moderate  with  an 
implementation score of 50%. All implemented activities aimed at reducing the burden of HIV in TB patients. The performance of implemented 
activities was in average 61% (n=179) and 82% (n=77) respectively regarding HIV testing among TB patients and antiretroviral therapy coverage 
in TB/HIV co-infected patients. Provision of isoniazid preventive therapy (IPT) was inexistent in this hospital due mainly to the lack of tuberculin 
skin test and isoniazid tablets. The prevalence of HIV among TB patients in this rural locality was 53%. This prevalence was 55% in females and 
44% in males (p=0.19). Conclusion: The implementation of collaborative TB/HIV activities in BDH was effective only regarding activities to 
reduce the burden of HIV among TB patients. There is urgent need to strengthen the capacity of this rural health facility in providing IPT services.  
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Background 
 
The human immunodeficiency virus (HIV) epidemic has led to the reemergence of tuberculosis (TB) worldwide and more particularly in countries 
with high HIV prevalence [1]. The HIV infection increases the risk of TB reactivation [2-5], causes rapid progression to active TB disease, and 
increases the risk of dying during a TB episode [6]. TB remains the most common opportunistic infection for people living with HIV, including those 
on antiretroviral therapy, and a leading cause of death for people living with HIV, especially in low and middle income countries [7]. In 2009 
globally, approximately 24 % of patients who died from TB were HIV co-infected [8].  
  
The impact of the TB/HIV cohabitation in the epidemiology and the clinical outcome of both diseases are of important programmatic concerns to 
TB and HIV programs and implications for policies include the need to promote TB and HIV/AIDS program collaboration [9] both at strategic and 
facility level. Actually, the strong relation between HIV and TB morbidity in high prevalence countries had stimulated debates and eventually 
influenced policy about integration of TB and HIV services. Nonetheless, the integration of these programs faces challenges all the way from policy 
making to integration at facility level [10]. In 2005, describing some of these challenges in the Democratic Republic of Congo, Martinot reported 
that some HIV activities were integrated only in 58% of TB clinics surveyed [11].  
  
In response to this need  of integrating TB/HIV activities the World Health Organization (WHO) in 2004 mapped out 12 key activities to be 
implemented by countries to ensure effective collaboration between TB and HIV programs [12]. From these key activities a set of core indicators 
was defined for monitoring and evaluating collaborative TB/HIV activities [13].  
  
According to UNAIDS, Cameroon has an HIV prevalence of 5.3% [14]. This relatively high HIV prevalence has undoubtedly contributed to the 
resurgence of TB and the growing burden of this disease in recent years in this country. Here, the estimated TB incidence (all forms) has risen 
from 81 (per 100 000) in 1990 to 182 in 2009 and the prevalence of HIV among TB patients was 40% in 2008 [8]. In 2006, Cameroon was among 
the 63 TB/HIV priority countries expected to commence the implementation of all recommended collaborative TB/HIV activities [15]. In line with 
this recommendation, TB and HIV management guidelines of this country indicate the implementation of collaborative TB/HIV activities at facility 
level, including among others tuberculin skin test (TST) prior to IPT provision [16,17]. The Batibo District Hospital (BDH) is such an operational 
site. The aim of this study was to assess the implementation and performance of this hospital regarding these activities. It was also aimed at 
determining the prevalence of HIV in TB patients in this rural health setting. This evaluation is important because it will inform implementers and 
program managers on the successes and challenges related to the expansion of TB/HIV activities in rural areas.  
  
  
Methods 
 
Setting  
  
The BDH is the district hospital of the Batibo Health District consisting of 13 health areas. Located in a rural area in the North West Region of 
Cameroon, this public hospital caters for a population of 101 576 and has a capacity of 86 beds. It is the first referral hospital for the 19 satellite 
health centers of the health district and provides a range of polyvalent health care to the population. The hospital has a functional center for 
diagnosis and treatment of TB (CDT) since October 2002. A passive case detection strategy is used to identify TB cases. All diagnosed TB cases are 
initiated on standard TB regimens, followed up and outcomes are reported according to national TB control guidelines [16]. The hospital also has a 
functional HIV/AIDS management unit since September 2005. This unit provides VCT, HIV treatment, care and support to the population of the 
health  district  and  the  surrounding  areas.  Integration  of  TB/HIV services  in  this  hospital  started  in  2005 with  the  creation  of  the  HIV/AIDS 
management.  
  
Design  
  
To evaluate the implementation and the performance of the collaborative TB/HIV activities, we carried out a cross sectional study in BDH in July 
2009.  The  evaluation  criteria  were  the  WHO  recommended  TB/HIV  activities  and  related  core  indicators,  representing  the  performance  of 
implemented activities were calculated as presented in additional material 1 [13]. To determine the prevalence of HIV in TB patients, records of 
all patients treated in the hospital for TB from 2003-2008 were reviewed.  
  
Data collection  
  
Data on the implementation of collaborative TB/HIV activities were collected through interviews with medical (1 medical doctor) and para-medical 
(3 nurses and 2 counselors) staff involved in TB and/or HIV programs in the hospital to determine enabling factors and obstacles for collaborative 
TB/HIV activities at facility level. In this study, an activity was qualified as implemented when it was delivered in the hospital as per reported by 
staff or registers. Data on the performance of implemented activities and the prevalence of HIV were determined through review of registers (HIV 
and TB) as well as drugs stocks cards for routine programmatic data for the period 2003-2008. Actually, a structured questionnaire was used to 
extract data related to core indicators of collaborative TB/HIV activities as well as the HIV sero-status of patients treated in the hospital. For each 
TB patient, we collected socio-demographic data (age, sex, residence) and information related to HIV, ART and cotrimoxazole prophylaxis therapy 
(CPT) status. For each HIV patient we collected information related to the screening of latent TB and Isoniazid Preventive Therapy (IPT).  
  
Statistical Analysis  
  
The  implementation  level  of  the  hospital  with  regards  to  the  WHO-recommended  collaborative  TB/HIV  activities  was  determined  as  the 
implementation score of the recommended activities. This score was a rate calculated using as numerator the total number of recommended 
activities effectively implemented in the hospital and as denominator the total number of recommended activities for the operational level. The Page number not for citation purposes  3 
performance of implemented activities was represented by the related core indicators. The core indicators assessed were the following: TB patients 
tested for HIV, HIV patients screened for TB, TB/HIV patients on ART (also representing the level of HIV care and support), TB/HIV patients on 
cotrimoxazole Preventive Therapy (CPT) and HIV patients on IPT. These indicators were calculated as the proportions of patients who benefited 
from the related services. For the analysis of these core indicators as well as the HIV sero-status of TB patients, data were entered and analyzed 
using Epi Info (version 3.5.1, CDC, Atlanta). The core indicators and prevalence were expressed in percentages. Chi-square (X2) test, with a 
significant level at 5% was used to compare frequencies.  
  
Ethical Clearance  
  
This study was a desk review analysis without contact with human subjects. The research protocol was approved by the ethics committee of the 
University of Heidelberg and the Batibo District Hospital administration authorized the conduct.  
  
  
Results 
 
A total of 293 patients were enrolled on TB treatment from 2003 to 2008. 54% (158) were males. The age ranged from 3 to 63 years (median = 
31 years). Children below 15 years of age represented 2.7% (N= 8) of the cohort while the age group 25-44 accounted for 57.7% (N=169) of the 
study population. From 2005 to 2008 the HIV unit initiated 638 people living with HIV/AIDS on ART. Additional material 2 depicts the status of 
the implementation of collaborative TB/HIV activities in BHD and factors enabling or hindering the implementation of these activities.  
  
Additional material 1 shows that of the 8 WHO recommended collaborative TB/HIV activities implementable at facility level, only 4 were being 
implemented in BDH at the time of this review, giving an implementation score of 50%. The analysis of staff interviews shows that the non-
implementation  of  IPT  activities  was  attributed  to  the  lack  of  technical  skills  of  staff  in  providing  TST  and  IPT  services  coupled  with  the 
unavailability of TST kits and INH in the hospital. The implementation of HIV testing among TB patients with provision of ART to eligible cases was 
boosted by the availability and affordability of HIV tests and ARV drugs as the result of the creation of the HIV unit in hospital in 2005.  
  
From the 293 TB patients analyzed, 61% (179/293) were tested for HIV and of those 99% (177/179) had a conclusive HIV test result. This HIV 
testing rate among TB patients varied across years from 17% in 2003 to 94% in 2008, with a pick at 96% in 2007 (Figure 1). Of the 177 persons 
having a conclusive HIV test result, 94 were positive for HIV, giving a prevalence rate of 53% (95%CI: 45- 60). This prevalence was 55% (95% 
CI: 44- 65) in females as compared to 44% (95%CI: 34-55) in males with no significant statistical difference between the two sexes (p=0.19). The 
age of HIV positive TB cases ranged from 17 to 60 years with a mean age of31±8 and 35±9 years respectively for females and males. From the 94 
TB/HIV co-infected patients, 78 (83%) did a CD4 count. From this number, 77 (82%) were enrolled on ART. Enrolment on ART varied across years 
to a maximum rate of 92% (34/37) in 2008 (Figure 2).The ART coverage rate also represents the level of HIV care and support to TB/HIV 
patients. It was not possible to calculate the core indicator related to the implementation of CPT because though delivery of free cotrimoxazole was 
effective in hospital, routine data on this activity was inaccurate due to inconsistent reporting in the registers. Furthermore, no HIV patient was on 
IPT in the hospital at the time of the review. Table 1 summarizes the core indicators (performance) of collaboration TB/HIV activities in the 
hospital for the study period.  
  
  
Discussion 
 
This evaluation has shown that,  with an implementation score of 50%, the implementation of collaborative TB/HIV activities in BDH is only 
moderate. Not implementing the so called 3Is activities in the hospital has contributed for 75% in this result. Actually, screening of HIV patients for 
TB infection and provision of IPT to eligible cases is not done in BDH. This service gap is not specific to this hospital, but goes across HIV 
treatment centers (HTCs) in Cameroon. Indeed, countrywide less than 10% of HTCs provide IPT services to HIV infected patients with latent TB 
infection [18]. Like argued by Harries et al. [19], this situation in BDH is related to the technical (lack of skills) and logistical (lack of test kits) 
challenges hindering the use of tuberculin skin test (TST) as well as the fear of care providers to initiate in IPT patients in whom active tuberculosis 
cannot be completely excluded. In BDH, these challenges are compounded by the unavailability of Isoniazid (INH) for IPT in the hospital. This lack 
of implementation stands in sharp contrast to the compelling evidence on the effectiveness of IPT in reducing the risk of tuberculosis in HIV 
patients [19]. It has been reported still by Harries that one of the reasons for the non implementation of IPT in countries is that at program level, it 
is not clear as to who assumes the responsibility for planning and implementing IPT activities [20]. Should it be the TB or the HIV program? 
According to the WHO the implementation of IPT services is the responsibility of the National HIV program [13]. However, this organization 
recommends the setting up at central level of a coordinating body for collaborative TB/HIV activities with the mandate to: develop joint strategic 
plans, mobilize resources, build capacity, implement and monitor collaborative TB/HIV activities. This coordination body should comprise of experts 
from the national HIV and TB programs, and other partners working in this field of co-infection TB/HIV. The absence of this body in a country may 
jeopardize national implementation of such activities [13]. This body was recently created (October 2009) in Cameroon. This may also explain the 
weaknesses observed in the implementation of IPT services in the country during the study period. Four out of 5 (80%) of the recommended 
activities to reduce the burden of HIV among TB patients were being implemented in BDH. Only 1 (one) of these activities was lacking. This 
missing activity was HIV prevention among TB patients, notably the provision of free condoms to patients at TB unit. Free condoms provision to 
the population, including to HIV or TB patients is not a policy in Cameroon. Instead condoms are made affordable to the populations through a 
subsidized cost of $US 0.25 per unit (4 condoms). Therefore, in addition to other HIV prevention methods, staff at TB clinics should emphasize on 
systematic counseling of TB patients in practicing safe sex, notably condom use.  
  
HIV testing among TB patients increased remarkably in 2005. This improvement coincided in time with the opening of the HIV/AIDS unit in the 
hospital in 2005. This improved performance can be explained by the integration of TB/HIV services in the same facility. In BDH, this integration 
boosted the morale of health workers in requesting HIV tests from patients, while increasing the willingness of patients in accepting HIV testing. Page number not for citation purposes  4 
Indeed, 93% of HIV testing conducted among TB patients was during the period 2006-2008, corresponding to the period after the creation of the 
HIV unit in the hospital. This very good rate needs though to been seen in relation to the low detection rate for TB during the evaluation period, 
but also clearly underlines the advantages of integrating affordable TB/HIV services in the same health facility as highlighted by Yumo et al.(2011) 
in another study still in Batibo District Hospital [21]. It is worth to remark that the high HIV testing uptake recorded in BDH among TB patients is 
also attributable to the provider-initiated HIV testing and counseling (PITC) (or opt-out-approach) introduced in the hospital in 2007. As compared 
to the opt-in-approach used in hospital before 2007, PITC is more effective in increasing HIV testing uptake, and most importantly it is feasible 
even rural health settings as previously reported in BDH [22] and elsewhere [23]. With an HIV testing rate of 94% in 2008, the target of the 
Global Plan 2006-2015 of STOP TB to HIV-test and counsel at least 85% of TB patients in DOTS programs [13]; is already achieved in Batibo 
Health District. Continuous efforts of programs managers at all levels are needed to maintain this performance by 2015. In particular, managers 
should ensure regular supply of HIV testing kits to the facility in a bid to avoid stock outs that may disrupt this already achieved performance.  
  
The proportion of TB/HIV co-infected patients enrolled on ART was 82% (n=77). This ART coverage rate is higher than the 36% observed at 
national level in 2008[8]. This high performance is attributed to the strong link between the TB and HIV units of the hospital. Here TB patients are 
systematically referred by the TB/HIV counselor to the HIV unit for HIV testing. Cases diagnosed with HIV infection are further investigated for 
ART eligibility; eligible cases initiated on ART and followed up according to the national guidelines [17]. It is interesting to observe that only 25% 
(3/12) of eligible cases were enrolled on ART during the period (2003-2005) before the creation of the HIV unit as compared to 90% (74/82) 
during the period (2006-2008) after the creation of this unit. This finding clearly demonstrates the effectiveness of having both TB and HIV units in 
the same health facility as a strategy to speed up ART coverage among TB/HIV co-infected patients and further supports the need for integrating 
TB/HIV services as mentioned above.  
  
CPT  coverage  rate  could  not  be  calculated  because  TB  registers  at  the  TB  unit  had  no  provision  to  track  CPT  status.  On  the  other  hand, 
cotrimoxazole registers at the HIV unit was inconsistently filled and more so had no provision to track the TB status of HIV patients on CPT. CPT 
and even ART reporting gap at global level was already outlined by Gunnerberg et al. (2008) who found that only 1/3 of countries was reporting 
data on CPT and ART among TB/HIV co-infected patients [24]. To ensure effective monitoring and evaluation of collaborative TB/HIV activities, 
routine data collection registers should include the following specifications: 1) The HIV register should have provision to track TB co-infection, TB 
treatment, IPT and CPT status of patients; 2) TB registers should have provision to track HIV co-infection, ART and CPT; and 3) cotrimoxazole 
registers should have provision to track TB co-infection, ART, INH, TB treatment. Furthermore, implementation of CPT in BDH was found to be 
hampered by recurrent stock outs of free cotrimoxazole due to lack of supply from the central level. This weakness needs to be appropriately 
addressed so as to enable TB/HIV co-infected patients on care in this hospital benefiting from CPT effect in mortality reduction [25].  
  
HIV prevalence (53%) among TB patients in BDH was higher than the 40% reported by WHO for the national level in 2008 [8], but similar to the 
52% reported in a urban district hospital in Douala (Cameroon) still in 2008 by Sume et al. [26]. This finding suggests that, in contrast to the 
general population where HIV prevalence is significantly higher in the cities as compared to the rural areas [27], the burden of HIV infection 
among the subpopulation of TB patients may be similar between cities and rural localities. Nevertheless, this high HIV prevalence among TB 
patients in BDH should be interpreted with caution since it may have been affected by a selection bias. Indeed, migration of Batibo natives from 
the cities to seek care in BDH is common. Secondly, Batibo is a transit zone in the trans-african (Cameroon-Nigeria) highway with occasional influx 
of outsiders. It is possible with these phenomena that the prevalence of HIV be higher in Batibo Health District as compared to typical rural areas. 
The TB/HIV co-infection rate, though not statistically significant was higher in females. This result parallels previous studies in Cameroon [24,28] 
and further supports evidence of the feminization of HIV infection in Cameroon [27].  
  
This study has some limitations. The data was collected through staff interviews and registers reviews. These methods may have introduced some 
information biases either from the staff or inaccurate reporting in the registers. Nevertheless, the TB and HIV/AIDS programs were funded by the 
Global Fund (GF) as from 2005 [21]. Considering the data management exigencies of GF funded programs, these biases if they exist should be 
minimal.  
  
  
Conclusion 
 
In conclusion, the implementation of collaborative TB/HIV activities in BDH was only moderate due mainly to the non implementation of IPT 
activities despite the existence of both TB and HIV units in the hospital. The performance of implemented activities was good regarding HIV testing 
among TB patients and excellent concerning HIV care and support to TB/HIV co-infected. The prevalence of HIV in TB patients was high in BDH. 
Strengthening the capacity of the BDH in the 3Is activities and particularly in IPT services is urgently needed to achieve complete collaborative 
TB/HIV activities in this rural health facility. Addressing this gap in IPT provision should be easier now since according to the 2010 WHO Stop TB 
recommendation, TST is not more required to initiate HIV patients on IPT [29].  
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Table 1: Summary table of performance indicators of WHO collaborative TB/HIV activities in Batibo  District Hospital 
No  Core indicators  Performance of implemented TB/HIV 
activities 
   numerator  denominator  Value (%) 
Activities to reduce the burden of HIV in people infected with TB 
1  Proportion of TB patients tested for HIV  179  293  61 
2 
Proportion  of  TB/HIV  co-infected  patients  enrolled  in  pre-ART  register  or  ART  register  once 
started on ART during TB treatment  (HIV care and support)  
77  94  82 
3  Proportion of TB/HIV co-infected patients initiated on ART  77  94  82 
4 
Proportion of TB/HIV co-infected patients started on or continued on previously initiated CPT 
during TB treatment 
Data not 
available*   
5  Availability and distribution of free condoms at the TB clinic  No 
 
Activities to reduce the burden of TB in people living with HIV (The 3Is) 
6 
Proportion  of  adults  and  children  enrolled  in  HIV  care  whose  TB  status  were  assessed  and 
recorded during their last visit.     
0  638  0 
7 
Proportion of adults and children newly enrolled on HIV care who are started on treatment for 
latent TB infection (are given at least one dose of IPT) during the reporting period. 
0  638  0 
8  Practice of TB control measures in the hospital  No    
*CPT is implemented, but reporting is inconsistent 
  